Procyon Corporation

PCYN

US7428063009

Pharmaceuticals

Delayed OTC Markets Other stock markets 15:18:52 2024-06-28 EDT			5-day change	1st Jan Change
0.23 ^USD	+0.44%		-21.77%	+34.90%

05-24	Procyon Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	CI
02-22	Procyon Corporation Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	CI

Procyon Corporation Announces Resignation of Paul E. Kudelko, Sr. as Board of Directors

July 12, 2021 at 01:31 pm

On July 6, 2021, Dr. Paul E. Kudelko, Sr. gave notice to the Board of Directors of Procyon Corporation of his resignation for personal reasons, effective immediately. The Company is in the process of reviewing certain candidates to fill the vacancy.

Latest news about Procyon Corporation

Procyon Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	05-24	CI
Procyon Corporation Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	02-22	CI
Procyon Corporation Reports Earnings Results for the First Quarter Ended September 30, 2023	11-22	CI
Procyon Corporation Reports Earnings Results for the Full Year Ended June 30, 2023	23-09-28	CI
Procyon Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	23-05-15	CI
Procyon Corporation Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	23-02-14	CI
Procyon Corporation Reports Earnings Results for the First Quarter Ended September 30, 2022	22-11-14	CI
Procyon Corporation Reports Earnings Results for the Full Year Ended June 30, 2022	22-09-28	CI
Procyon Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022	22-05-11	CI
Procyon Corporation Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021	22-02-14	CI
Procyon Corporation Reports Earnings Results for the First Quarter Ended September 30, 2021	21-11-19	CI
Procyon Corporation Reports Earnings Results for the Full Year Ended June 30, 2021	21-10-08	CI
Procyon Corporation Announces Board Changes	21-07-20	CI
Procyon Corporation Announces Resignation of Paul E. Kudelko, Sr. as Board of Directors	21-07-12	CI
Procyon Corporation Reports Earnings Results for the Third Quarter Ended March 31, 2021	21-05-24	CI
Procyon Corporation Reports Earnings Results for the Second Quarter Ended December 31, 2020	21-02-26	CI
Procyon Corporation Enters into Lease for Warehouse and Office in Clearwater, Florida	21-01-27	CI
Procyon Corporation Reports Earnings Results for the Full Year Ended June 30, 2020	20-10-06	CI
Procyon Corporation Reports Earnings Results for the Third Quarter Ended March 31, 2020	20-06-24	CI
Procyon Corporation Reports Earnings Results for the Second Quarter Ended December 31, 2019	20-02-19	CI
Procyon Corporation Reports Earnings Results for the First Quarter Ended September 30, 2019	19-11-19	CI
Procyon Corporation Reports Earnings Results for the Full Year Ended June 30, 2019	19-09-30	CI
Procyon Corporation Reports Earnings Results for the Third Quarter Ended March 31, 2019	19-05-17	CI
Procyon Corporation Reports Earnings Results for the Second Quarter Ended December 31, 2018	19-02-14	CI
Procyon Corporation Announces Executive Changes	18-01-16	CI

Chart Procyon Corporation

Duration

Period

More charts

Company Profile

Procyon Corporation operates through its subsidiaries AMERX Health Care Corporation (AMERX) and Sirius Medical Supply, Inc. (Sirius). AMERX develops and markets proprietary medical products used in the treatment of pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation and other skin problems. Its product lines include AMERX, AMERIGEL, HELIX3 Bioactive Collagen, EXTREMIT-EASE Compression Garment and Advantagen Surgical Collagen. AMERX markets a line of AMERIGEL advanced skin and wound care products made with Oakin, that promote healing in wound and problematic skin conditions, including AMERIGEL Hydrogel Wound Dressing, AMERIGEL Post Op Surgical Kits, AMERIGEL Saline Wound Wash, AMERIGEL Care Lotion, and AMERIGEL Barrier Lotion. HELIX3 is available in Collagen Powder and Collagen Matrix. Its wound care product includes AMERX Calcium Alginate Dressing, AMERX Foam Dressing, AMERX Gauze Dressing, AMERX Hyrdocolloid Dressing, and AMERX Wound Care Kits.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
PROCYON CORPORATION	+34.90%	1.86M
ELI LILLY AND COMPANY	+56.03%	819B
JOHNSON & JOHNSON	-6.93%	351B
MERCK & CO., INC.	+17.29%	329B
ABBVIE INC.	+9.60%	298B
ASTRAZENECA PLC	+16.57%	242B
ROCHE HOLDING AG	+2.04%	225B
NOVARTIS AG	+13.31%	217B
AMGEN INC.	+8.18%	168B
PFIZER, INC.	-2.80%	158B